Evidence mapPaperPMID 41578189Full record

ArticleBMC infectious diseases2026

Predictors of culture status in patients with persistent smear-positive pulmonary tuberculosis at two months of treatment.

Junais Koleri, Faraj S Howady, Jay P N Singh, Sara Al Balushi, Muna Al Maslamani

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junais KoleriDivision of Infectious Diseases, Hamad Medical Corporation, PO Box 3050, Doha, Qatar. JKoleri@hamad.qa.
Faraj S HowadyDivision of Infectious Diseases, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Jay P N SinghLaboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
Sara Al BalushiDivision of Infectious Diseases, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Muna Al MaslamaniDivision of Infectious Diseases, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn pulmonary tuberculosis (TB), smear positivity usually declines with effective treatment, but the time to non-infectiousness varies, creating uncertainty about the optimal duration of isolation. The Centers for Disease Control and Prevention (CDC) 2005 guidelines allow discharge before smear conversion to home isolation (restricted to healthcare visits until smear negativity) if no vulnerable household contacts are present, whereas hospitalized patients are advised to remain under airborne precautions until they have three consecutive negative smears. The practice in Qatar is to keep sputum smear positive TB patients in isolation facilities until smear negativity is achieved. Relying solely on smear conversion as a marker of non-infectiousness is problematic, as persistent smear positivity may reflect nonviable bacilli, or in some cases non-tuberculous mycobacteria, rather than ongoing transmission risk. This study evaluates the culture status of patients who remained smear-positive after two months of therapy to determine bacillary viability and reassess the validity of smear-based isolation practices.

aimThis study aimed to determine the proportion of culture-positive cases among pulmonary tuberculosis patients remaining smear-positive at two months of treatment and identify factors predictive of culture-negative status to support earlier isolation discontinuation. METHODOLOGY: A retrospective review of electronic medical records (2016–2024) was conducted at a tertiary TB center in Qatar, targeting patients smear-positive at two months. Data included demographics, disease extent (e.g. cavitary lesions), initial and two-month acid-fast bacilli (AFB) smear counts, two-month AFB cultures, drug resistance, and comorbidities.

resultsWe identified 88 patients who remained smear-positive at two months of treatment. Among them, 61.4% were culture positive. Patients without cavitary lesions on the initial chest X-ray and those with two-month AFB counts < 10/100 fields had a 69% negative predictive value for culture negativity.

conclusionsOver half of persistent smear-positive patients remain potentially infectious at two months. However, those without cavitary lesions and with low AFB counts in the two months smear could be candidates for earlier isolation discontinuation, optimizing resources and reducing patient burden. These findings support individualized isolation protocols. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Antitubercular AgentsMycobacterium tuberculosisSputumTuberculosis, PulmonaryAdultBacilloscopyFemaleHumansMaleMiddle AgedPatient IsolationQatarRetrospective StudiesAntitubercular AgentsCulture statusPulmonary TBRespiratory isolationSmear positivityTB infectivity

Identifiers

PMID41578189
PMCPMC12911143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.